314 related articles for article (PubMed ID: 15151996)
1. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
[TBL] [Abstract][Full Text] [Related]
2. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
[TBL] [Abstract][Full Text] [Related]
4. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases.
Saxon A; Zhu D; Zhang K; Allen LC; Kepley CL
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):563-8. PubMed ID: 15640700
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
[TBL] [Abstract][Full Text] [Related]
7. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
8. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
9. FcepsilonRI-FcgammaRII coaggregation inhibits IL-16 production from human Langerhans-like dendritic cells.
Kepley CL; Zhang K; Zhu D; Saxon A
Clin Immunol; 2003 Aug; 108(2):89-94. PubMed ID: 12921754
[TBL] [Abstract][Full Text] [Related]
10. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
11. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions.
Senis YA; Antrobus R; Severin S; Parguiña AF; Rosa I; Zitzmann N; Watson SP; García A
J Thromb Haemost; 2009 Oct; 7(10):1718-26. PubMed ID: 19682241
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
15. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels.
Gimborn K; Lessmann E; Kuppig S; Krystal G; Huber M
J Immunol; 2005 Jan; 174(1):507-16. PubMed ID: 15611277
[TBL] [Abstract][Full Text] [Related]
16. Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release.
Tkaczyk C; Okayama Y; Metcalfe DD; Gilfillan AM
Int Arch Allergy Immunol; 2004 Mar; 133(3):305-15. PubMed ID: 15017113
[TBL] [Abstract][Full Text] [Related]
17. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
18. Mast cell activation is differentially affected by heat shock.
Mortaz E; Redegeld FA; van der Heijden MW; Wong HR; Nijkamp FP; Engels F
Exp Hematol; 2005 Aug; 33(8):944-52. PubMed ID: 16038788
[TBL] [Abstract][Full Text] [Related]
19. The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
Waterman PM; Marschner S; Brandl E; Cambier JC
Immunol Lett; 2012 Mar; 143(1):122-30. PubMed ID: 22370159
[TBL] [Abstract][Full Text] [Related]
20. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
